PDS Biotechnology (NASDAQ:PDSB) Earns Buy Rating from HC Wainwright
HC Wainwright reiterated their buy rating on shares of PDS Biotechnology (NASDAQ:PDSB – Free Report) in a report issued on Thursday,Benzinga reports. The firm currently has a $21.00 price target on the stock. Separately, B. Riley dropped their price target on shares of PDS Biotechnology from $9.00 to $7.00 and set a “buy” rating on […]
